1
|
Ayupova G, Litvinov S, Akhmetova V, Minniakhmetov I, Mokrysheva N, Khusainova R. Population Characteristics of the Spectrum and Frequencies of CFTR Gene Mutations in Patients with Cystic Fibrosis from the Republic of Bashkortostan (Russia). Genes (Basel) 2024; 15:1335. [PMID: 39457459 PMCID: PMC11507265 DOI: 10.3390/genes15101335] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/30/2024] [Revised: 10/04/2024] [Accepted: 10/15/2024] [Indexed: 10/28/2024] Open
Abstract
BACKGROUND/OBJECTIVES Cystic fibrosis (CF) is one of the most common autosomal-recessive disorders worldwide. The incidence of CF depends on the prevalence of cystic fibrosis transmembrane conductance regulator gene (CFTR) mutations in the population, which is determined by genetic diversity and ethnicity. METHODS The search for the causes of mutations in the transmembrane conductance regulator gene (CFTR) was carried out using targeted next-generation sequencing (NGS) on the Illumina platform in patients with cystic fibrosis from the Republic of Bashkortostan (Russia), taking into account the ethnic structure of the sample. RESULTS A total of 35 distinct causal variants were found in 139 cases from 129 families. Five (F508del, E92K, 3849+10kbC>T, CFTRdele2.3, L138ins) explain 78.7% of identified CF causal alleles. Variants N13103K and 394delTT were found in four families each. Variants 2143delT, S1196X, W1282X, Y84X, G194R, and 1525-1G>A, as well as the two previously described complex alleles-c. [S466X; R1070Q] and str.[G509D;E217G]-were found in two or three families each. Twenty additional variants occurred only once. Variant c.3883_3888dup has not been described previously. Thus, regional and ethnic features were identified in the spectrum of frequencies of pathogenic variants of the CFTR gene in the three major sub-groups of patients-Russians, Tatars, and Bashkirs. CONCLUSIONS Taking into account these results, highlighting the genetic specificity of the region, a more efficient search for CFTR mutations in patients can be performed. In particular it is possible to choose certain test kits for quick and effective genetic screening before use of NGS sequencing.
Collapse
Affiliation(s)
- Guzel Ayupova
- Department of Medical Genetics and Fundamental Medicine, Bashkir State Medical University, 450008 Ufa, Russia;
| | - Sergey Litvinov
- Institute of Biochemistry and Genetics, 450000 Ufa, Russia; (S.L.); (V.A.)
| | - Vita Akhmetova
- Institute of Biochemistry and Genetics, 450000 Ufa, Russia; (S.L.); (V.A.)
| | | | | | - Rita Khusainova
- Department of Medical Genetics and Fundamental Medicine, Bashkir State Medical University, 450008 Ufa, Russia;
- Institute of Biochemistry and Genetics, 450000 Ufa, Russia; (S.L.); (V.A.)
- Endocrinology Research Centre, 117292 Moscow, Russia; (I.M.); (N.M.)
| |
Collapse
|
2
|
Chernykh V, Krasovsky S, Solovova O, Adyan T, Stepanova A, Marnat E, Shtaut M, Sedova A, Sorokina T, Beskorovainaya T, Kondratyeva E, Shchagina O, Polyakov A. Pathogenic Variants and Genotypes of the CFTR Gene in Russian Men with Cystic Fibrosis and CBAVD Syndrome. Int J Mol Sci 2023; 24:16287. [PMID: 38003474 PMCID: PMC10671388 DOI: 10.3390/ijms242216287] [Citation(s) in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/21/2023] [Revised: 11/09/2023] [Accepted: 11/11/2023] [Indexed: 11/26/2023] Open
Abstract
Pathogenic CFTR variants cause cystic fibrosis (CF), and CF-related disorders (CF-RD), including bilateral aplasia of the vas deferens (CBAVD). The spectrum of clinical manifestations depends on the CFTR genotype. The frequency and spectrum of the CFTR variants vary between populations and clinical groups. CFTR variants and genotypes were analyzed in Russian men with CF (n = 546) and CBAVD syndrome (n = 125). Pathogenic variants were detected in 93.95% and 39.2% of the CF and CBAVD alleles, respectively. The most frequent c.1521_1523del (F508del; p.Phe508del) variant was found in 541 (49.5%) CF alleles. A total of 162 CFTR genotypes were revealed in CF patients, including 152 homozygous and 394 compound-heterozygous. The most common CF-genotype was F508del/F508del (24.9%). Other frequent CF-genotypes were F508del/3849+10kbC>T, F508del/CFTRdele2,3, and F508del/E92K. CF-causing variants and/or 5T allele were found in 88% of CBAVD patients: 5T/CFTRmut (48.0%), CFTRmut/N (17.6%), CFTRmut/CFTRmut (6.4%), 5T/5T (10.4%), 5T/N (5.6%) and N/N (12.0%), with the most common CBAVD-genotype being F508del/5T (29.6%). The allele frequencies of F508del, CFTRdele2,3 394delTT, and 3849+10kbC>T were significantly higher in CF patients. L138ins/L138ins, 2184insA/E92K, and L138ins/N genotypes were found in CBAVD, but not in CF patients. The results indicate certain differences in the frequency of some CFTR variants and genotypes in Russian CF and CBAVD patients.
Collapse
Affiliation(s)
- Vyacheslav Chernykh
- Research Centre for Medical Genetics, 115522 Moscow, Russia; (S.K.); (O.S.); (T.A.); (A.S.); (M.S.); (A.S.); (T.S.); (T.B.); (E.K.); (O.S.); (A.P.)
- Pirogov Russian National Research Medical University of the Ministry of Healthcare of the Russian Federation, 117997 Moscow, Russia;
| | - Stanislav Krasovsky
- Research Centre for Medical Genetics, 115522 Moscow, Russia; (S.K.); (O.S.); (T.A.); (A.S.); (M.S.); (A.S.); (T.S.); (T.B.); (E.K.); (O.S.); (A.P.)
| | - Olga Solovova
- Research Centre for Medical Genetics, 115522 Moscow, Russia; (S.K.); (O.S.); (T.A.); (A.S.); (M.S.); (A.S.); (T.S.); (T.B.); (E.K.); (O.S.); (A.P.)
| | - Tagui Adyan
- Research Centre for Medical Genetics, 115522 Moscow, Russia; (S.K.); (O.S.); (T.A.); (A.S.); (M.S.); (A.S.); (T.S.); (T.B.); (E.K.); (O.S.); (A.P.)
| | - Anna Stepanova
- Research Centre for Medical Genetics, 115522 Moscow, Russia; (S.K.); (O.S.); (T.A.); (A.S.); (M.S.); (A.S.); (T.S.); (T.B.); (E.K.); (O.S.); (A.P.)
| | - Ekaterina Marnat
- Pirogov Russian National Research Medical University of the Ministry of Healthcare of the Russian Federation, 117997 Moscow, Russia;
| | - Maria Shtaut
- Research Centre for Medical Genetics, 115522 Moscow, Russia; (S.K.); (O.S.); (T.A.); (A.S.); (M.S.); (A.S.); (T.S.); (T.B.); (E.K.); (O.S.); (A.P.)
| | - Anna Sedova
- Research Centre for Medical Genetics, 115522 Moscow, Russia; (S.K.); (O.S.); (T.A.); (A.S.); (M.S.); (A.S.); (T.S.); (T.B.); (E.K.); (O.S.); (A.P.)
| | - Tatyana Sorokina
- Research Centre for Medical Genetics, 115522 Moscow, Russia; (S.K.); (O.S.); (T.A.); (A.S.); (M.S.); (A.S.); (T.S.); (T.B.); (E.K.); (O.S.); (A.P.)
| | - Tatyana Beskorovainaya
- Research Centre for Medical Genetics, 115522 Moscow, Russia; (S.K.); (O.S.); (T.A.); (A.S.); (M.S.); (A.S.); (T.S.); (T.B.); (E.K.); (O.S.); (A.P.)
| | - Elena Kondratyeva
- Research Centre for Medical Genetics, 115522 Moscow, Russia; (S.K.); (O.S.); (T.A.); (A.S.); (M.S.); (A.S.); (T.S.); (T.B.); (E.K.); (O.S.); (A.P.)
| | - Olga Shchagina
- Research Centre for Medical Genetics, 115522 Moscow, Russia; (S.K.); (O.S.); (T.A.); (A.S.); (M.S.); (A.S.); (T.S.); (T.B.); (E.K.); (O.S.); (A.P.)
| | - Aleksandr Polyakov
- Research Centre for Medical Genetics, 115522 Moscow, Russia; (S.K.); (O.S.); (T.A.); (A.S.); (M.S.); (A.S.); (T.S.); (T.B.); (E.K.); (O.S.); (A.P.)
| |
Collapse
|
3
|
Chernykh V, Sorokina T, Sedova A, Shtaut M, Solovova O, Marnat E, Adyan T, Beskorovaynaya T, Stepanova A, Shchagina O, Polyakov A. L138ins Variant of the CFTR Gene in Russian Infertile Men. Genes (Basel) 2023; 14:1407. [PMID: 37510311 PMCID: PMC10379041 DOI: 10.3390/genes14071407] [Citation(s) in RCA: 2] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/24/2023] [Revised: 06/02/2023] [Accepted: 07/06/2023] [Indexed: 07/30/2023] Open
Abstract
(1) Introduction: Pathogenic variants in the CFTR (Cystic Fibrosis Transmembrane conductance Regulator, OMIM: 602421) gene cause Cystic Fibrosis (CF, OMIM: 219700) and CF-related disorders (CF-RD), often accompanied by obstructive azoospermia due to congenital bilateral aplasia of vas deferens (CBAVD, OMIM: 277180) in male patients. The L138ins (c.413_415dup; p. (Leu138dup)) is a mild variant in the CFTR gene that is relatively common among CF-patients in Slavic populations. The frequency of this variant in Russian infertile men has not been sufficiently studied; (2) Materials and Methods: The sample consisted of 6033 Russian infertile men. The patients were tested for 22 common in Russian populations pathogenic variants of the CFTR gene and the IVS9Tn-polymorphic locus of the intron 9. Molecular-genetic studies were performed using amplified fragment length polymorphism (AFLP-PCR), multiplex ligation-dependent probe amplification (MLPA), and nested PCR (for analysis of the IVS9Tn-polymorphic locus); (3) Results: Pathogenic variants in the CFTR were detected in 3.9% of patients. The most frequent variants were F508del and CFTRdele2.3(21kb), accounted for 61.0% and 7.1% of detected variants, respectively. The L138ins variant was detected in 17 (0.28%) individuals: one of them was homozygous, 10 patients were heterozygous, and 6 patients were compound-heterozygous (F508del/L138ins, n = 4; L138ins/N1303K, n = 1; L138ins/5T, n = 1). Two pathogenic CF-causing variants in the CFTR gene were detected in 8 patients, including 7 compound heterozygous (F508del/L138ins, n = 4; F508del/N1303K, n = 1; 2184insA/E92K, n = 1; 3849+10kbC>T/E92K, n = 1) and one homozygous (L138ins/L138ins). The L138ins variant was found in 7 out of 16 (43.75%) chromosomes in six of these patients. The most common pathogenic variant, F508del, was identified in five out of them, in 5 of 16 (31.25%) chromosomes. The allele frequency (AF) of the L138ins variant in the sample has been found to be 0.0014.; (4) Conclusions: The L138ins variant of the CFTR gene is the third most common variant after F508del and CFTRdele2.3(kb) among Russian infertile men.
Collapse
Affiliation(s)
- Vyacheslav Chernykh
- Research Centre for Medical Genetics, 115522 Moscow, Russia; (T.S.); (A.S.); (M.S.); (O.S.); (T.A.); (T.B.); (A.S.); (O.S.); (A.P.)
- Pirogov Russian National Research Medical University of the Ministry of Healthcare of the Russian Federation, 117997 Moscow, Russia;
| | - Tatyana Sorokina
- Research Centre for Medical Genetics, 115522 Moscow, Russia; (T.S.); (A.S.); (M.S.); (O.S.); (T.A.); (T.B.); (A.S.); (O.S.); (A.P.)
| | - Anna Sedova
- Research Centre for Medical Genetics, 115522 Moscow, Russia; (T.S.); (A.S.); (M.S.); (O.S.); (T.A.); (T.B.); (A.S.); (O.S.); (A.P.)
| | - Maria Shtaut
- Research Centre for Medical Genetics, 115522 Moscow, Russia; (T.S.); (A.S.); (M.S.); (O.S.); (T.A.); (T.B.); (A.S.); (O.S.); (A.P.)
| | - Olga Solovova
- Research Centre for Medical Genetics, 115522 Moscow, Russia; (T.S.); (A.S.); (M.S.); (O.S.); (T.A.); (T.B.); (A.S.); (O.S.); (A.P.)
| | - Ekaterina Marnat
- Pirogov Russian National Research Medical University of the Ministry of Healthcare of the Russian Federation, 117997 Moscow, Russia;
| | - Tagui Adyan
- Research Centre for Medical Genetics, 115522 Moscow, Russia; (T.S.); (A.S.); (M.S.); (O.S.); (T.A.); (T.B.); (A.S.); (O.S.); (A.P.)
| | - Tatyana Beskorovaynaya
- Research Centre for Medical Genetics, 115522 Moscow, Russia; (T.S.); (A.S.); (M.S.); (O.S.); (T.A.); (T.B.); (A.S.); (O.S.); (A.P.)
| | - Anna Stepanova
- Research Centre for Medical Genetics, 115522 Moscow, Russia; (T.S.); (A.S.); (M.S.); (O.S.); (T.A.); (T.B.); (A.S.); (O.S.); (A.P.)
| | - Olga Shchagina
- Research Centre for Medical Genetics, 115522 Moscow, Russia; (T.S.); (A.S.); (M.S.); (O.S.); (T.A.); (T.B.); (A.S.); (O.S.); (A.P.)
| | - Aleksandr Polyakov
- Research Centre for Medical Genetics, 115522 Moscow, Russia; (T.S.); (A.S.); (M.S.); (O.S.); (T.A.); (T.B.); (A.S.); (O.S.); (A.P.)
| |
Collapse
|
4
|
Zinchenko RA, Ginter EK, Marakhonov AV, Petrova NV, Kadyshev VV, Vasilyeva TP, Alexandrova OU, Polyakov AV, Kutsev SI. Epidemiology of Rare Hereditary Diseases in the European Part of Russia: Point and Cumulative Prevalence. Front Genet 2021; 12:678957. [PMID: 34527017 PMCID: PMC8435741 DOI: 10.3389/fgene.2021.678957] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/10/2021] [Accepted: 07/15/2021] [Indexed: 11/20/2022] Open
Abstract
The issue of point prevalence, cumulative prevalence (CP), and burden of rare hereditary diseases (RHD), comprising 72–80% of the group of rare diseases, is discussed in many reports and is an urgent problem, which is associated with the rapid progress of genetic technology, the identification of thousands of genes, and the resulting problems in society. This work provides an epidemiological analysis of the groups of the most common RHDs (autosomal dominant, autosomal recessive, and X-linked) and their point prevalence (PP) and describes the structure of RHD diversity by medical areas in 14 spatially remote populations of the European part of Russia. The total size of the examined population is about 4 million. A total of 554 clinical forms of RHDs in 10,265 patients were diagnosed. The CP for all RHDs per sample examined was 277.21/100,000 (1:361 people). It is worth noting that now is the time for characterizing the accumulated data on the point prevalence of RHDs, which will help to systematize our knowledge and allow us to develop a strategy of care for patients with RHDs. However, it is necessary to address the issues of changing current medical classifications and coding systems for nosological forms of RHDs, which have not kept pace with genetic advances.
Collapse
Affiliation(s)
- Rena A Zinchenko
- Research Centre for Medical Genetics, Moscow, Russia.,Department of Public Health Research, N.A. Semashko National Research Institute of Public Health, Moscow, Russia
| | | | | | | | | | - Tatyana P Vasilyeva
- Department of Public Health Research, N.A. Semashko National Research Institute of Public Health, Moscow, Russia
| | - Oksana U Alexandrova
- Department of Public Health Research, N.A. Semashko National Research Institute of Public Health, Moscow, Russia
| | | | | |
Collapse
|
5
|
Kondratyeva E, Efremova A, Melyanovskaya Y, Petrova N, Satsuk N, Bulatenko N, Bukharova T, Zodbinova A, Sherman V, Kashirskaya N, Zinchenko R, Kutsev S, Goldshtein D. Clinical and genetic characterization of patients with cystic fibrosis and functional assessment of the chloride channel with the pathogenic variant c.831G>A (p.Trp277*), described for the first time. Gene 2020; 761:145023. [PMID: 32758581 DOI: 10.1016/j.gene.2020.145023] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/23/2020] [Revised: 06/07/2020] [Accepted: 07/30/2020] [Indexed: 10/23/2022]
Abstract
The clinical pictures of the disease of two Russian patients with cystic fibrosis with a rare nonsense variant c.831G>A (p.Trp277*) are described. The first case is a patient with the genotype comprising variant c.54-5940_273+10250del21kb (CFTRdele2,3), and the genotype of the second case included variant c.1521_1523delCTT (F508del). Patient 1, whose genotype had two class I genetic variants, revealed severe violations of CFTR synthesis based on the intestinal current measurements (ICM) and results obtained in the intestinal organoids. In both cases of patients with genetic variant c.831G>A, a severe course of cystic fibrosis was observed.
Collapse
Affiliation(s)
- E Kondratyeva
- Research Centre for Medical Genetics, 115522, 1 Moskvorechye St., Moscow, Russia.
| | - A Efremova
- Research Centre for Medical Genetics, 115522, 1 Moskvorechye St., Moscow, Russia
| | - Yu Melyanovskaya
- Research Centre for Medical Genetics, 115522, 1 Moskvorechye St., Moscow, Russia.
| | - N Petrova
- Research Centre for Medical Genetics, 115522, 1 Moskvorechye St., Moscow, Russia
| | - N Satsuk
- Nizhnevartovsk Regional Clinical Children's Hospital, 628609, 30 Severnaya St., Nizhnevartovsk, Russia
| | - N Bulatenko
- Research Centre for Medical Genetics, 115522, 1 Moskvorechye St., Moscow, Russia
| | - T Bukharova
- Research Centre for Medical Genetics, 115522, 1 Moskvorechye St., Moscow, Russia
| | - A Zodbinova
- Research Centre for Medical Genetics, 115522, 1 Moskvorechye St., Moscow, Russia
| | - V Sherman
- Research Centre for Medical Genetics, 115522, 1 Moskvorechye St., Moscow, Russia
| | - N Kashirskaya
- Research Centre for Medical Genetics, 115522, 1 Moskvorechye St., Moscow, Russia
| | - R Zinchenko
- Research Centre for Medical Genetics, 115522, 1 Moskvorechye St., Moscow, Russia
| | - S Kutsev
- Research Centre for Medical Genetics, 115522, 1 Moskvorechye St., Moscow, Russia
| | - D Goldshtein
- Research Centre for Medical Genetics, 115522, 1 Moskvorechye St., Moscow, Russia
| |
Collapse
|
6
|
Petrova NV, Kashirskaya NY, Krasovskiy SA, Amelina EL, Kondratyeva EI, Marakhonov AV, Vasilyeva TA, Voronkova AY, Sherman VD, Ginter EK, Kutsev SI, Zinchenko RA. Clinical Presentation of the c.3844T>C (p.Trp1282Arg, W1282R) Variant in Russian Cystic Fibrosis Patients. Genes (Basel) 2020; 11:E1137. [PMID: 32992607 PMCID: PMC7600230 DOI: 10.3390/genes11101137] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/14/2020] [Revised: 09/12/2020] [Accepted: 09/23/2020] [Indexed: 11/25/2022] Open
Abstract
The goal was to study the phenotypic manifestations of c.3844T>C (p.Trp1282Arg, W1282R) variant, a CF-causing mutation, in patients from the Russian Federation. Clinical manifestations and complications (the age at CF diagnosis, sweat test, pancreatic status, lung function, microbial infection, body mass index (BMI), the presence of meconium ileus (MI), diabetes, and severe liver disease) were compared in four groups: group 1-patients carrying c.3844T>C and severe class I or II variant in trans; group 2-3849+10kbC>T/F508del patients; group 3-F508del/F508del patients; and group 4-patients with W1282R and "mild" variant in trans. Based on the analyses, W1282R with class I or II variant in trans appears to cause at least as severe CF symptoms as F508del homozygotes as reflected in the early age of diagnosis, high sweat chloride concentration, insufficient pancreatic function, and low lung function, in contrast to 3849+10kbC-T/F508del compound heterozygotes having milder clinical phenotypes. The W1282R pathogenic variant is seemed to lead to severe disease phenotype with pancreatic insufficiency similarly to the F508del homozygous genotype.
Collapse
Affiliation(s)
- Nika V. Petrova
- Research Centre for Medical Genetics, Russian Federation, Moskvorechie St., 1, 115522 Moscow, Russia; (N.V.P.); (S.A.K.); (E.I.K.); (A.V.M.); (T.A.V.); (A.Y.V.); (V.D.S.); (E.K.G.); (S.I.K.); (R.A.Z.)
| | - Nataliya Y. Kashirskaya
- Research Centre for Medical Genetics, Russian Federation, Moskvorechie St., 1, 115522 Moscow, Russia; (N.V.P.); (S.A.K.); (E.I.K.); (A.V.M.); (T.A.V.); (A.Y.V.); (V.D.S.); (E.K.G.); (S.I.K.); (R.A.Z.)
| | - Stanislav A. Krasovskiy
- Research Centre for Medical Genetics, Russian Federation, Moskvorechie St., 1, 115522 Moscow, Russia; (N.V.P.); (S.A.K.); (E.I.K.); (A.V.M.); (T.A.V.); (A.Y.V.); (V.D.S.); (E.K.G.); (S.I.K.); (R.A.Z.)
- Pulmonology Research Institute under FMBA of Russia, Orekhoviy boulevard, 28, 115682 Moscow, Russia;
| | - Elena L. Amelina
- Pulmonology Research Institute under FMBA of Russia, Orekhoviy boulevard, 28, 115682 Moscow, Russia;
| | - Elena I. Kondratyeva
- Research Centre for Medical Genetics, Russian Federation, Moskvorechie St., 1, 115522 Moscow, Russia; (N.V.P.); (S.A.K.); (E.I.K.); (A.V.M.); (T.A.V.); (A.Y.V.); (V.D.S.); (E.K.G.); (S.I.K.); (R.A.Z.)
| | - Andrey V. Marakhonov
- Research Centre for Medical Genetics, Russian Federation, Moskvorechie St., 1, 115522 Moscow, Russia; (N.V.P.); (S.A.K.); (E.I.K.); (A.V.M.); (T.A.V.); (A.Y.V.); (V.D.S.); (E.K.G.); (S.I.K.); (R.A.Z.)
| | - Tatyana A. Vasilyeva
- Research Centre for Medical Genetics, Russian Federation, Moskvorechie St., 1, 115522 Moscow, Russia; (N.V.P.); (S.A.K.); (E.I.K.); (A.V.M.); (T.A.V.); (A.Y.V.); (V.D.S.); (E.K.G.); (S.I.K.); (R.A.Z.)
| | - Anna Y. Voronkova
- Research Centre for Medical Genetics, Russian Federation, Moskvorechie St., 1, 115522 Moscow, Russia; (N.V.P.); (S.A.K.); (E.I.K.); (A.V.M.); (T.A.V.); (A.Y.V.); (V.D.S.); (E.K.G.); (S.I.K.); (R.A.Z.)
| | - Victoria D. Sherman
- Research Centre for Medical Genetics, Russian Federation, Moskvorechie St., 1, 115522 Moscow, Russia; (N.V.P.); (S.A.K.); (E.I.K.); (A.V.M.); (T.A.V.); (A.Y.V.); (V.D.S.); (E.K.G.); (S.I.K.); (R.A.Z.)
| | - Evgeny K. Ginter
- Research Centre for Medical Genetics, Russian Federation, Moskvorechie St., 1, 115522 Moscow, Russia; (N.V.P.); (S.A.K.); (E.I.K.); (A.V.M.); (T.A.V.); (A.Y.V.); (V.D.S.); (E.K.G.); (S.I.K.); (R.A.Z.)
| | - Sergey I. Kutsev
- Research Centre for Medical Genetics, Russian Federation, Moskvorechie St., 1, 115522 Moscow, Russia; (N.V.P.); (S.A.K.); (E.I.K.); (A.V.M.); (T.A.V.); (A.Y.V.); (V.D.S.); (E.K.G.); (S.I.K.); (R.A.Z.)
| | - Rena A. Zinchenko
- Research Centre for Medical Genetics, Russian Federation, Moskvorechie St., 1, 115522 Moscow, Russia; (N.V.P.); (S.A.K.); (E.I.K.); (A.V.M.); (T.A.V.); (A.Y.V.); (V.D.S.); (E.K.G.); (S.I.K.); (R.A.Z.)
| |
Collapse
|
7
|
Ma C, Wang R, Li T, Li H, Wang B. Analysis of CNVs of CFTR gene in Chinese Han population with CBAVD. Mol Genet Genomic Med 2020; 8:e1506. [PMID: 32951344 PMCID: PMC7667304 DOI: 10.1002/mgg3.1506] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/20/2020] [Revised: 08/28/2020] [Accepted: 08/31/2020] [Indexed: 01/09/2023] Open
Abstract
Background Congenital bilateral absence of vas deferens (CBAVD) is an important disease of male infertility, which affects 1%–2% of infertile population. In addition to common mutations of CFTR, copy number variants (CNVs) have also been implicated as one of the pathogenesis of CBAVD. The present study aimed to investigate the genetic contribution of CFTR CNVs in Chinese Han population with CBAVD. Methods Two hundred and sixty‐three CBAVD patients were recruited. Genomic DNA was extracted from peripheral blood samples. The Multiplex Ligation‐dependent Probe Amplification assay was performed which targets the region of the CFTR gene. Results Among 263 Chinese men affected with CBAVD in this study, 5 (1.90%) patients were detected for copy number variants in the region of CFTR gene (4 of them carried partial deletions and 1 of them carried partial duplication of CFTR gene). Conclusions The study showed that the rate of CFTR CNVs in Chinese population with CBAVD were basically consistent with the previous reports. And the study first revealed genetic risk of CNVs of CFTR on a large sample size of CBAVD patients in Chinese Han population, which prompted that it was necessary to detect CNVs of CFTR in Chinese Han people with CBAVD.
Collapse
Affiliation(s)
- Chengquan Ma
- Department of Urology, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, P. R. China.,Graduate School of Peking Union Medical College, Beijing, P. R. China
| | - Ruyi Wang
- Graduate School of Peking Union Medical College, Beijing, P. R. China.,Center for Genetics, National Research Institute for Family Planning, Beijing, P. R. China
| | - Tengyan Li
- Center for Genetics, National Research Institute for Family Planning, Beijing, P. R. China
| | - Hongjun Li
- Department of Urology, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, P. R. China
| | - Binbin Wang
- Graduate School of Peking Union Medical College, Beijing, P. R. China.,Center for Genetics, National Research Institute for Family Planning, Beijing, P. R. China
| |
Collapse
|
8
|
Petrova NV, Kashirskaya NY, Vasilyeva TA, Kondratyeva EI, Zhekaite EK, Voronkova AY, Sherman VD, Galkina VA, Ginter EK, Kutsev SI, Marakhonov AV, Zinchenko RA. Analysis of CFTR Mutation Spectrum in Ethnic Russian Cystic Fibrosis Patients. Genes (Basel) 2020; 11:E554. [PMID: 32429104 PMCID: PMC7288340 DOI: 10.3390/genes11050554] [Citation(s) in RCA: 9] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/30/2020] [Revised: 05/08/2020] [Accepted: 05/13/2020] [Indexed: 12/14/2022] Open
Abstract
The distribution and frequency of the CFTR gene mutations vary considerably between countries and ethnic groups. Russians are an East Slavic ethnic groups are native to Eastern Europe. Russians, the most numerous people of the Russian Federation (RF), make about 80% of the population. The aim is to reveal the molecular causes of CF in ethnic Russian patients as comprehensively as possible. The analysis of most common CFTR mutations utilized for CF diagnosis in multiethnic RF population accounts for about 83% of all CF-causing mutations in 1384 ethnic Russian patients. Variants c.1521_1523delCTT (F508del), c.54-5940_273+10250del21kb (CFTRdele2,3), c.2012delT (2143delT), c.2052_2053insA (2184insA), and c.3691delT (3821delT) are most typical for CF patients of Russian origin. DNA of 154 CF patients, Russian by origin, in whom at least one mutant allele was not previously identified (164 CF alleles), was analyzed by Sanger sequencing followed by the multiplex ligase-dependent probe amplification (MLPA) method. In addition to the 29 variants identified during the previous test for common mutations, 91 pathogenic CFTR variants were also revealed: 29 missense, 19 nonsense, 14 frame shift in/del, 17 splicing, 1 in frame ins, and 11 copy number variations (CNV). Each of the 61 variants was revealed once, and 17 twice. Each of the variants c.1209G>C (E403D), c.2128A>T (K710X), c.3883delA (4015delA), and c.3884_3885insT (4016insT) were detected for three, c.1766+1G>A (1898+1G>A) and c.2834C>T (S945L) for four, c.1766+1G>C (1898+1G>C) and c.(743+1_744-1)_(1584+1_1585-1)dup (CFTRdup6b-10) for five, c.2353C>T (R785X) and c.4004T>C (L1335P) for six, c.3929G>A (W1310X) for seven, c.580-1G>T (712-1G>T for eight, and c.1240_1244delCAAAA (1365del5) for 11 unrelated patients. A comprehensive analysis of CFTR mutant alleles with sequencing followed by MLPA, allowed not only the identification of 163 of 164 unknown alleles in our patient sample, but also expansion of the mutation spectrum with novel and additional frequent variants for ethnic Russians.
Collapse
Affiliation(s)
- Nika V. Petrova
- Research Centre for Medical Genetics, Moskvorechje Street, 1, 115478 Moscow, Russia; (N.Y.K.); (T.A.V.); (E.I.K.); (E.K.Z.); (A.Y.V.); (V.D.S.); (V.A.G.); (E.K.G.); (S.I.K.); (A.V.M.); (R.A.Z.)
| | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|